Nrf2 expression in pancreatic stellate cells promotes progression of cancer

Yu Tanaka1, Shin Hamada1, Ryotaro Matsumoto1

  • 1Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) promotes pancreatic stellate cell (PSC) activation, which drives pancreatic ductal adenocarcinoma progression. Inhibiting Nrf2 in PSCs may offer a novel therapeutic strategy for pancreatic cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Systemic Nrf2 deletion was previously shown to slow pancreatic cancer growth in KPC mice.
  • The specific cell type mediating this effect remained unclear.

Purpose of the Study:

  • To identify the cell type responsible for Nrf2-mediated pancreatic cancer progression.
  • To investigate the role of Nrf2 in pancreatic stellate cells (PSCs) and their contribution to pancreatic cancer.

Main Methods:

  • Examined human pancreatic cancers for NRF2-target gene expression in α-smooth muscle actin-positive cells.
  • Cultured PSCs from Nrf2-deleted mice and assessed proliferation and migration.
  • Evaluated the effect of conditioned medium from Nrf2-deleted PSCs on pancreatic cancer cells.
  • Coinjected KPC mouse-derived cancer cells with wild-type or Nrf2-deleted PSCs in immunodeficient mice.

Main Results:

  • Elevated NRF2-target gene products were found in PSCs of human pancreatic cancers.
  • Nrf2-deleted PSCs exhibited reduced proliferation and migration.
  • Conditioned medium from Nrf2-deleted PSCs had diminished growth-stimulating effects on cancer cells.
  • Tumor growth was significantly smaller when cancer cells were coinjected with Nrf2-deleted PSCs compared to wild-type PSCs.

Conclusions:

  • Nrf2 actively promotes PSC function, sustaining KPC pancreatic cancer progression.
  • Nrf2 in PSCs is a potential therapeutic target for pancreatic cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
96